{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:05:43Z","timestamp":1784786743151,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The extensive expression of STING in patients with non-small cell lung cancer (NSCLC) is closely associated with overall survival and other factors. Activation of the STING pathway can suppress NSCLC. However, the clinical translation of STING agonists remains hindered by challenges such as off-target effects, metabolic instability, and suboptimal pharmacokinetics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this study, we engineered two oncolytic adenoviruses (OAds), OAd-HcGAS and OAd-McGAS, expressing human or murine cGAS, respectively, using an Ad5\/3 chimeric adenovirus platform under regulation by the hTERT promoter to evaluate whether OVs carrying the cGAS gene are capable of specifically activating the STING pathway within tumors and enhancing the anti-tumor efficacy of OVs both\n                      <jats:italic>in vitro<\/jats:italic>\n                      and\n                      <jats:italic>in vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In vitro<\/jats:italic>\n                      , OAd-HcGAS exhibited robust replication and potent cytolytic activity in tumor cells. It activated the STING\u2013TBK1\u2013IRF3 signaling axis, triggering a strong type I interferon (IFN-I) and pro-inflammatory cytokine response without compromising viral replication. In a murine Lewis lung carcinoma allograft model, intratumoral (i.t.) administration of OAd-McGAS led to substantial cGAS expression and consequential activation of the STING pathway. Moreover, the combination with anti-PD-L1 therapy resulted in tumor regression in over half of the cases. Notably, this armed oncolytic virus strategy enhanced the activation and infiltration of multiple immune cell populations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Collectively, these findings establish cGAS-expressing oncolytic adenoviruses as a novel and effective therapeutic strategy for lung cancer treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1904206","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:38:16Z","timestamp":1784785096000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncolytic adenovirus armed with cGAS activates STING pathway and enhances antitumor immunity in lung cancer with superior combined efficacy of PD-L1 therapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Qing-Wen","family":"Wang","sequence":"first","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Wei","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sen","family":"Shi","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Peng","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jun","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Ning","family":"Yue","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Qiang","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Lei","family":"Peng","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Mei","family":"Yu","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sheng","family":"He","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Peng","family":"Zheng","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hui","family":"Fu","sequence":"additional","affiliation":[{"name":"College of Life Sciences and Bioengineering, Beijing Jiaotong University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13947","article-title":"Recombinant human adenovirus type 5 (Oncorine) reverses resistance to immune checkpoint inhibitor in a patient with recurrent non-small cell lung cancer: A case report","volume":"12","author":"Zhang","year":"2021","journal-title":"Thorac Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1450203","article-title":"Strategies for engineering oncolytic viruses to enhance cancer immunotherapy","volume":"15","author":"Yin","year":"2024","journal-title":"Front Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"10522","DOI":"10.3390\/ijms221910522","article-title":"Concepts in oncolytic adenovirus therapy","volume":"22","author":"Mantwill","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.01.003","article-title":"The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch-like conformational changes in the activation loop","volume":"6","author":"Zhang","year":"2014","journal-title":"Cell Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.019","article-title":"Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization","volume":"39","author":"Li","year":"2013","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.4049\/jimmunol.190.supp.207.2","article-title":"Cyclic GMP-AMP synthase (cGAS) is a cytosolic DNA sensor that activates type I interferon pathway by generating a second messenger","volume":"190","author":"Sun","year":"2013","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.04.046","article-title":"Cyclic [G(2\u2032,5\u2032) pA(3\u2032,5\u2032)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase","volume":"153","author":"Gao","year":"2013","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111132","article-title":"Activation of cGAS-STING signaling pathway promotes liver fibrosis and hepatic sinusoidal microthrombosis","volume":"125","author":"Luo","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1399926","article-title":"Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies","volume":"15","author":"Huang","year":"2024","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado4618","article-title":"ATR inhibition activates cancer cell cGAS\/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer","volume":"10","author":"Taniguchi","year":"2024","journal-title":"Sci Adv"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122687","article-title":"Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS\/STING pathway activation and immunogenetic cell death","volume":"348","author":"Guo","year":"2024","journal-title":"Life Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13603","article-title":"STING activator 2'3'-cGAMP enhanced HSV-1-based oncolytic viral therapy","volume":"18","author":"Sibal","year":"2024","journal-title":"Mol Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.04.010","article-title":"The DNA structure-specific endonuclease MUS81 mediates DNA sensor STING-dependent host rejection of prostate cancer cells","volume":"44","author":"Ho","year":"2016","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.03.041","article-title":"Genome-derived cytosolic DNA mediates type I interferon-dependent rejection of B cell lymphoma cells","volume":"11","author":"Shen","year":"2015","journal-title":"Cell Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12964-024-01586-x","article-title":"Role of STING in the treatment of non-small cell lung cancer","volume":"22","author":"Tang","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1807616","DOI":"10.1002\/adfm.201807616","article-title":"Viromimetic STING agonist-loaded hollow polymeric nanoparticles for safe and effective vaccination against Middle East respiratory syndrome coronavirus","volume":"29","author":"Lin","year":"2019","journal-title":"Adv Funct Mater"},{"key":"B18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/adfm.202204589","article-title":"Reduction sensitive polymers delivering cationic platinum drugs as STING agonists for enhanced chemo-immunotherapy","volume":"32","author":"Zhang","year":"2022","journal-title":"Adv Funct Mater"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202300854","article-title":"Sono-driven STING activation using semiconducting polymeric nanoagonists for precision sono-immunotherapy of head and neck squamous cell carcinoma","volume":"35","author":"Jiang","year":"2023","journal-title":"Adv Mater"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.12.023","article-title":"p53 engages the cGAS\/STING cytosolic DNA sensing pathway for tumor suppression","volume":"83","author":"Ghosh","year":"2023","journal-title":"Mol Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-020-01247-w","article-title":"cGAS-STING pathway in cancer biotherapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e001372","DOI":"10.1136\/jitc-2020-001372","article-title":"Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1-mediated immunoescape via STING-IFN signaling and extracellular vesicles","volume":"8","author":"Cheng","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.12.162","article-title":"Radiation therapy promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation","volume":"112","author":"Du","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28310","article-title":"DNA virus oncoprotein HPV18 E7 selectively antagonizes cGAS-STING-triggered innate immune activation","volume":"95","author":"Lou","year":"2023","journal-title":"J Med Virol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02608-14","article-title":"Unabated adenovirus replication following activation of the cGAS\/STING-dependent antiviral response in human cells","volume":"88","author":"Lam","year":"2014","journal-title":"J Virol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005415","article-title":"E2F\/Rb family proteins mediate interferon induced repression of adenovirus immediate early transcription to promote persistent viral infection","volume":"12","author":"Zheng","year":"2016","journal-title":"PloS Pathog"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.13695","article-title":"Viral and cellular interactions during adenovirus DNA replication","volume":"593","author":"Charman","year":"2019","journal-title":"FEBS Lett"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01154-16","article-title":"Adenovirus early proteins and host sumoylation","volume":"7","author":"Sohn","year":"2016","journal-title":"mBio"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1994.tb06837.x","article-title":"Adenovirus replication and transcription sites are spatially separated in the nucleus of infected cells","volume":"13","author":"Pombo","year":"1994","journal-title":"EMBO J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq7483","article-title":"Stepwise virus assembly in the cell nucleus revealed by spatiotemporal click chemistry of DNA replication","volume":"10","author":"Gomez-Gonzalez","year":"2024","journal-title":"Sci Adv"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.02.019","article-title":"New frontiers in the cGAS-STING intracellular DNA-sensing pathway","volume":"57","author":"Dvorkin","year":"2024","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/v14010092","article-title":"Breaking entry-and species barriers: LentiBOOST\u00ae plus polybrene enhances transduction efficacy of dendritic cells and monocytes by adenovirus 5","volume":"14","author":"Strack","year":"2022","journal-title":"Viruses"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.virs.2024.11.001","article-title":"Construction and validation of a mouse model for studying severe human adenovirus infections","volume":"39","author":"Chen","year":"2024","journal-title":"Virol Sin"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.05.015","article-title":"Local oncolytic adenovirotherapy produces an abscopal effect via tumor-derived extracellular vesicles","volume":"29","author":"Kakiuchi","year":"2021","journal-title":"Mol Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/cancers11040539","article-title":"Strategies to improve cancer immune checkpoint inhibitors efficacy, other than abscopal effect: A systematic review","volume":"11","author":"Longo","year":"2019","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1904206\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:38:17Z","timestamp":1784785097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1904206\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2026.1904206"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1904206","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"1904206"}}